IACS-70654

N/A

Report date: 2024/12/26 10:30:45
NME

Base Information

Drug NameIACS-70654
Drug Alias NameIACS-70654
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp300-CBP transcription factors inhibitors
TargetsBromodomain-containing protein 1p300-CBP transcription factors
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesBaylor College Of Medicine
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A